로딩 중…
지수 로딩 중…
Teva Pharmaceutical Industries Limited
TEVA· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
IL
IL$31.46-3.38%
2026-06-18
Price Chart
Teva Pharmaceutical Industries Limited+84.41%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $36.63B |
| Revenue | $17.35B |
| Net Income | $1.56B |
| Total Assets | $40.04B |
| Net Assets | $8.23B |
| Value | |
| P/E | 23.42x |
| P/B | 4.45x |
| PEG | 0.32x |
| P/S | 2.11x |
| EV/EBITDA | 15.23x |
| FCF Yield | 3.20% |
| Profitability | |
| ROE | 19.01% |
| ROA | 3.91% |
| Op. Margin | 13.19% |
| Revenue Growth | 2.31% |
| Earnings Growth | 72.43% |
| Financial Health | |
| Debt Ratio | 386.58% |
| Total Debt | $16.91B |
| FCF | $1.17B |
| Cash | $3.74B |
| Current Ratio | 1.01x |
| Net Debt/EBITDA | 4.03x |
| Performance | |
| 1Y Return | 84.41% |
| 1M Return | -7.66% |
| From 52W High | -15.77% |
| 1Y MDD | -21.79% |
| Trading | |
| Volume | 10,001,264 shares |
| Trading Value | $316M |
| Per Share | |
| EPS | $1.23 |
| BPS | $6.88 |